CDK1 and cancer: In addition, AZD1775 has been shown to be cytotoxic to cancer cells independently of the presence of TP53 mutation10–12, because activation of CDK1 promoted by WEE1 inhibition leads to early mitotic entry and mitotic catastrophe13.